ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2022 American Transplant Congress

June 4-8, 2022 in Boston, MA

The ATC program is built in the Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z
  • Race Inequity in Liver Transplant Waitlisting: Effect Modification by Psychosocial Factors and the Stanford Integrated Psychosocial Assessment for Transplant

    S. Deutsch-Link1, L. Nephew2, E. Weinberg3, R. Weinrieb4, M. Serper3

  • Race Misclassification in Kidney Transplantation Research

    A. Kernodle, V. Thompson, X. Chen, D. Segev, T. Purnell, M. McAdams-DeMarco

  • Race-Based Differences in Simultaneous Liver and Kidney Transplant Utilization and Outcomes

    L. Subbaraj1, J. Lai2, G. Cullaro2

  • Racial and Immunologic Disparities Impact Access to Repeat Kidney Transplantation Among Patients with Previous Failed Kidney Allograft

    B. P. Lovasik1, R. Zhang1, R. Lynch1, R. Patzer1, A. Adams2

  • Racial Barriers to Kidney Transplant After Listing, 2015 – 2020

    W. T. McKinney1, D. Schladt2, J. Miller2, T. Weaver2, J. Pyke2, T. Madhusoodanan3, A. K. Israni1

  • Racial Differences in HLA Mismatch Potential Among Kidney Registrations

    A. Robinson1, K. Lindblad1, D. Stewart1, J. Kim2, V. Casingal3, P. Lalli3, J. Lunz4, C. Murphey5, M. Pavlakis6

  • Racial Differences in the Predictability of Donor-Derived Cell-Free DNA Among Renal Transplant Recipients

    M. D. Williams1, N. Nimmagadda1, S. Patel2, O. Olaitan1

  • Racial Disparities in Preemptive Kidney Transplantation Beyond Listing Estimated Glomerular Filtration Rate

    K. L. King1, S. Husain2, S. Mohan2

  • Racial Equity in Living Donor Kidney Transplant: Center Variation and Opportunities for Progress

    L. M. McElroy, T. Schappe, S. Peskoe, V. Wang, D. Mohottige, C. D. Scales, J. Pendergast, L. Boulware

  • Racial Hot Spots of Non-Preemptive Kidney Transplant Wait Listing, 2010-2020

    R. B. Buchalter, J. D. Schold

  • Racial/Ethnic Disparities in Rates of Living Donor Liver Transplant Are Partly Explained by Socioeconomic Deprivation in Adults

    S. Frey, T. Ishaque, C. Qin, A. Cameron, A. Massie, D. Segev, E. King

  • Randomized, Phase 4 Study Evaluating the Pharmacokinetics and Tolerability of the New Tacrolimus Tablet Formulation (Tacrobell Tab) in Kidney Transplant Recipients

    A. Han1, E. Cho1, H. Y. Woo1, C. Ara1, H. Lee2, Y. Kim3, Y. Park4, J. Oh4, S. Min1, J. Ha1

  • Rapid Formalin-Fixed Deceased Donor Kidney Biopsy Protocol – A Proof Of Concept

    M. R. Marvin1, G. Chen2, A. Kotru1, C. Koo1, P. Sanghi3, M. Moritz4, J. Clarke4, R. Hasz4

  • Rates Of Dermatology Follow-up And New Skin Cancer Diagnosis Among Solid Organ Transplant Recipients During The Covid-19 Pandemic

    R. Saranath, J. Gomez, B. Fernandez, E. Shah, S. Michalak, I. Ahronowitz

  • RBBP7 as a Novel Biomarker for the Molecular Diagnosis of BK Virus-Associated Nephropathy

    W. Yicun, W. Yuxuan, H. Xiaopeng

  • Re-Examining the Optimal Threshold for Donor Derived Cell Free DNA in Renal Allograft Rejection

    H. Murad1, M. Merzkani1, M. Ji1, S. Chang1, A. Malone1, R. Delos Santos1, T. Alhamad2

  • Re-Infection with SARS-CoV-2 in Solid-Organ Transplant Recipients: Incidence Density and Convalescent Immunity Prior to Re-Infection

    S. Morris1, S. Anjan1, S. Pallikkuth2, P. Frattaroli3, S. Courel4, A. Fernandez5, A. Natori6, L. Abbo7, S. Pahwa2, G. Guerra8, Y. Natori1

  • Re-Kidney Transplantation in Patients with Graft Failure: Survival Benefit by Age

    J. Ahn1, S. Sandal2, A. Massie1, D. Segev1, M. Cantarovich2, M. McAdams-DeMarco1

  • Real World Experience Utilizing Donor Kidneys at Risk for Acute Kidney Injury with Belatacept Based Maintenance Immunosuppression

    B. Sirandas, A. Chan, M. Eiting, T. Larson, C. Truax, L. Smith

  • Real-Life Prevention of Breakthrough SARS-CoV-2 Infections by mRNA Vaccines in Kidney Transplant Recipients vs Hemodialysis Patients

    D. Rodríguez-Espinosa, E. Montagud-Marrahi, J. Cacho, C. Arana, N. Taurizano, E. Hermida, J. Del Risco, J. Casals, A. Rosario, E. Cuadrado, N. Rodríguez, I. Revuelta, B. Bayès, P. Ventura-Aguiar, F. Cofan, E. Poch, F. Oppenheimer, M. Vera, L. Rodas, F. Maduell, F. Diekmann, A. Cases, J. Broseta, D. Cucchiari

  • Real-Life Tacrolimus Levels Are Associated with Biopsy-Proven Acute Rejection After the First Year Post-Kidney Transplantation

    S. Meziyerh, T. van Gelder, D. van der Helm, P. J. van der Boog, J. W. de Fijter, D. J. Moes, A. P. de Vries

  • Real-Time Application of Deep Learning in Diagnosis of Graft Fibrosis After Liver Transplantation Using Longitudinal Data

    A. Azhie1, D. Sharma2, P. Sheth1, W. Xu3, M. Bhat1

  • Real-Time Biometric Monitoring Using Wearable Devices for Pediatric Heart Transplant Rejection and Infection Surveillance

    D. Gandla1, J. B. Edelson2, E. Mukhtar1, J. Callanan1, H. Lad1, H. Gao1, J. Cornetta1, B. Keating1

  • Reality Capture Using Light Detection and Ranging 3D Photography of Liver Grafts for Volumetric Assessment: A Proof-of-Concept Preliminary Study

    K. E. Karakasi1, G. Katsanos2, I. Karolos3, V. Tsioukas3, G. Tsoulfas4

  • Reasons for Kidney Transplant Patients to Have Outpatient Urine Cultures in the First Year Post-Transplant: An Analysis of the USRDS

    V. Hemmige1, E. Akalin2, M. Kinkhabwala3

  • Reassessment of Previous Kidney Discards from a Single Large Organ Procurement Organization

    S. Bunnapradist1, T. Seto2, A. Cohen2, T. Rosenthal1, G. Danovitch1

  • Recipient and Center Factors Associated with Immunosuppression Practice Beyond the First Year After Liver Transplantation

    T. Bittermann1, D. Goldberg2

  • Recipient and Grafts Outcomes in Simultaneous Kidney and Pancreas Transplantation with Steroid Avoidance in the United States

    A. Cerise1, A. Dinesh2, V. Humphreville2, S. Jackson3, R. Kandaswamy2, S. Riad4

  • Recipient and Kidney Graft Outcomes of Human Immunodeficiency Virus Positive Deceased Donors in the United States

    K. J. Swanson1, R. El-Rifai1, A. Bregman1, R. Spong1, V. Kirchner2, T. Pruett2, S. Jackson3, S. M. Riad1

  • Recipient MCPggaac Haplotype is Associated with Poor Graft Survival in Recipients with De Novo Thrombotic Microangiopathy

    V. Petr1, D. Csuka2, P. Hruba3, Á. Szilágyi2, Z. Prohászka2, O. Viklicky1

  • Recipient Neutrophil Production of Myeloperoxidase is Required for NK Cell Activation During Acute Antibody Mediated Allograft Rejection

    Y. Mitsui1, D. Ueda1, S. Miyairi1, N. Dvorina1, K. S. Keslar1, A. Valujskikh1, B. William1, R. Fairchild2

  • Recipient Race Modifies the Association Between Obesity and Long Term Graft Outcomes After Renal Transplantation

    F. Jarrar1, K. Tennankore2, A. J. Vinson3

  • Recipient TIM4+ Macrophage is a Central Hub for Metabolic Homeostasis in Liver Transplantation: From Mouse-to-Human

    H. Hirao, K. Kadono, H. Kojima, K. J. Dery, D. G. Farmer, F. M. Kaldas, J. Kupiec-Weglinski

  • Recipient Treatment with Anti-CD122 mAb Prolongs Kidney Allograft Survival During Antibody-Mediated Rejection without Impacting NK Cell Activation within the Graft

    D. Okada, S. Miyairi, N. Dvorina, K. S. Keslar, A. Valujskikh, W. Baldwin, R. Fairchild

  • Recipient’s Age Does Not Impact Survival After Simultaneous Heart and Kidney Transplant

    F. Aziz1, F. Raza1, S. Parajuli1, T. Hess1, A. Feidler1, D. Mandelbrot2, A. Djamali1, R. Dhingra3

  • Recoverability of Diabetic Nephropathy of Donor Kidney After Kidney Transplantation

    K. Lee, J. Park

  • Recurrence of Focal Segmental Glomerulosclerosis After Kidney Transplantation According to Pre-Transplant Treatment

    H. Kwon, S. Shin, Y. Kim

  • Recurrence of Membranous Nephropathy After Kidney Transplantation – TANGO Consortium

    F. Hullekes1, A. Uffing1, L. Riella1, P. Cravedi2

  • Recurrent Cytomegalovirus and the Role of Secondary Prophylaxis in Heart and Lung Transplant Recipients

    S. N. Finder1, K. Harrison1, M. Morrison1, S. Rega2, I. Feurer2, C. Gorsline3, G. Satyanarayana3, S. Hamel1

  • Reduced CD45RA-CCR7- Tregs Subtypes in Highly Sensitised Patients Associates with a Failure to Regulate Memory IFNγ Production in Response to Donor Alloantigens

    C. Dudreuilh1, S. Basu1, O. Shaw2, H. Burton1, C. Domingo-Vila1, T. Tree1, G. Lombardi1, C. Scotta1, A. Dorling1

  • Reduced Dose Mycophenolate Does Not Increase the Risk of Rejection Following Renal Transplantation

    L. Bowman1, A. Webb1, S. Desai2, D. Patino3, V. Subramanian4, S. Mohammed5, M. Gosselin6, K. Robichaux5, J. Buggs4, A. Kumar7

  • Reduced Enterohepatic Recirculation of Mycophenolate and Lower Blood Concentrations Are Associated with the Stool Bacterial Microbiome

    P. A. Jacobson1, A. Saqr1, B. Carlson1, C. Staley2, A. Rashidi3, S. Holtan3, M. Al-Kofahi1, T. Kaiser2, M. MacMillan4, J. Young5, N. El Jurdi3, D. Weisdorf3, A. Khoruts6

  • Reducing Financial Burden for Living Donors: A Single Center Experience of Increased National Living Donor Assistance Center (NLDAC) Support

    T. Klair, K. Throgmorton, D. Oviedo, E. Cepeda

  • Reduction in Opioid Discharge Prescribing for Kidney Transplant Recipients Through Implementation of a Standardized Opioid Prescribing Policy

    S. Fredrick1, K. Dokus2, J. Cooley1, A. Dulen3, J. Melaragno1

  • Reduction of Discharge Opioid Prescriptions After Kidney Transplantation: A Quality Improvement Project

    A. W. Rogers, E. Rizk, J. T. Swan, S. G. Yi, M. Hobeika, R. R. McMillan, J. C. Krisl, H. Podder, A. O. Gaber, R. J. Knight

  • Reduction of Rabbit Anti-Thymocyte Globulin Dosing for Induction of Kidney Transplant During the COVID-19 Pandemic

    C. Burrelli1, S. Gundling1, D. Ecabert1, R. Powell1, A. Padiyar1, K. Andreoni1, K. Chavin2, A. Bixby1

  • Reflections on the Most Prolific United States Kidney Transplant Surgeon: A Career That Helped Define the Standard of Transplant Care

    C. Killian1, R. Reed2, P. MacLennan1, D. Anderson1, R. Cannon1, B. Orandi1, P. Porrett1, S. Sheikh1, C. Young1, M. J. Hanaway1, J. Locke1

  • Regional Variation in Early Effects of Acuity Circle-Based Liver Allocation

    T. Ivanics1, S. Nagai2, T. Kitajima2, S. Shimada2, T. Shamaa2, K. Collins2, M. Rizzari2, A. Yoshida2, D. Moonka2, M. Abouljoud2

  • Regulation of Cell Death During Cold Preservation of Marginal Human Kidneys

    J. R. DiRito1, G. Chickering1, J. Langford1, D. Stern1, D. Qin2, S. Hosgood3, M. Nicholson3, J. Pober4, E. Gavathiotis5, R. Kitsis5, G. Tietjen1

  • Regulatory Gene Pathways Are Upregulated in Heart Transplant Biopsies with Quilty Lesions

    Q. Cai, L. De Las Casas, J. Torrealba

  • Regulatory T and B Cell Responses Are Equally Compromised During Antibody-Mediated Rejection of Kidney Allografts

    K. Louis1, P. Fadakar2, C. Macedo2, M. Yamada2, M. Lucas2, X. Gu2, A. Zeevi2, P. Randhawa2, C. Lefaucheur3, D. Metes2

  • Regulatory T Cell PopulationsMay be Associated with Transplant Outcomes

    H. Shin, S. Heo, Y. Kim, N. Lee, Y. Kim, Y. Jung, H. Rim

  • Regulatory T Cells Suppress Memory IFN-Gamma Production in Highly Sensitised Patients

    C. Dudreuilh1, S. Basu1, O. Shaw2, H. Burton1, C. Domingo-Vila1, T. Tree1, G. Lombardi1, C. Scotta1, A. Dorling1

  • Regulatory T Cells Suppress Memory IL-17a Production in Highly Sensitised Patients with End-Stage Renal Disease

    C. Dudreuilh1, S. Basu1, O. Shaw2, H. Burton1, C. Domingo-Vila1, T. Tree1, G. Lombardi1, C. Scotta1, A. Dorling1

  • Rejection After Liver Transplantation: What Can We Learn from Transcriptomic Analysis?

    H. J. Braun1, D. Amara2, A. Zarinsefat1, G. Szabo1, Z. Laszik1, P. Stock1, N. Ascher1

  • Removing DSA and Region from Organ Allocation

    R. R. Goff1, A. R. Wilk1, J. Foutz1, A. Robinson1, S. E. Booker1, K. Bradbrook1, T. Mupfudze1, N. Turgeon2, M. Cooper3, D. Klassen1

  • Renal Allograft Lymphangiectasia: A Rare Post-Transplant Complication

    M. M. Ibrahim1, R. Delos Santos1, A. Java2

  • Renal Allograft Outcomes of Very High KDPI vs High KDPI Donor Kidneys

    R. Rattanavich, R. Villicana

  • Renal Allograft Rejection: New Paradigms in the T Cell Landscape Revealed by Single Cell RNAseq Analysis

    T. Shi1, A. Burg1, K. Roskin2, J. Rush3, B. Haraldsson3, A. Shields4, R. Alloway4, E. Woodle5, D. Hildeman1

  • Renal Failure is Reversible in the Majority of Patients Transplanted for Alcohol-Associated Hepatitis: A Review of the UNOS Database

    Y. Bekki, G. Im, T. Schiano, S. Florman

  • Renal Function After Orthotopic Liver Transplantation

    N. Kemmer1, z. Alam2, S. Desai3, L. Grater4, K. Robichaux5, S. Mohammed5, M. Gosselin4, A. Kumar6, J. Buggs7

  • Renal Function at Five Years from a Randomized Multicenter Trial of Belatacept-Based CNI Free and Early Steroid Withdrawal Immunosuppression

    E. Yanqui1, H. Hames1, A. R. Shields1, T. Shi1, A. L. Christianson1, J. Kremer2, A. Govil1, R. R. Alloway1, E. S. Woodle1

  • Renal Graft Outcomes in Simultaneous Heart-Kidney Transplantation

    K. Okumura, S. Ohira, M. Kai, K. Wolf, A. L. Gass, D. Spielvogel, N. Singh, D. Glicklich, D. John, T. Diflo, S. Lansman, S. Nishida, A. Dhand

  • Renal Transplantation and Statins Effects on Dyslipidemia in Renal Transplant Recipients

    Z. Arabi, A. Alghamdi, A. Alnasrullah, A. R. Altheaby, M. Tawhari, N. Alnazari

  • Renal Transplants In Hepatitis C Negative Recipients With Nucleic Acid Positive Donors Using Two Weeks Of DAA Prophylaxis (Rehanna – 2)

    N. M. Desai1, S. Leung1, J. Motter1, F. Naqvi2, N. Bair1, B. Barnaba2, D. Warren1, D. Segev1, C. Durand2

  • Repeat Kidney Transplantation from Living Donors Offers Comparable Outcomes as First Transplantation

    N. Oh, K. Lee, J. Rhu, J. Kim, G. Choi, J. Park, J. Joh

  • Reproductive Counseling in Kidney Transplant: Patient Needs and Current Practices

    S. Rajagopal1, J. Ritchie2, D. Seidman3, Y. Srisengfa4, E. R. Perito5, D. Adey6, M. Sarkar7

  • Research Publication Rates, Characteristics, and Perceptions of Solid Organ Transplant Pharmacy Residency Training: A Survey of Program Directors

    J. Melaragno1, D. Kovac2, S. Witek3, M. Harris4, K. Khalil5, M. Laub6, D. Quan7, A. Lichvar8

  • Residential Mobility of Lung Recipients

    W. M. Tsuang1, E. Jiang1, J. Curtis2

  • Resistance Isn’t Futile: The Independent Effect of Pumping Resistance on Long-Term Kidney Graft Survival

    D. Stewart1, J. Foutz1, L. Kamal2, G. Gupta2

  • Resource Expenditure in the Evaluation of Older Donors for Heart Transplant: An Impediment to Donor Pool Expansion?

    B. Wayda1, J. G. Zaroff2, N. Neidlinger3, P. Geraghty4, R. P. Wood5, J. Nieto5, T. C. Pearson6, B. Nicely7, K. K. Khush1

  • Resource Utilization in Liver Transplant Patients Based on Psychological Evaluation of High Risk vs. Non-High Risk

    K. Barber1, D. Chism2, R. Sauls3, R. Shargo3, M. Gosselin4, S. Mohammed3, K. Robichaux3, A. Kumar5, J. Buggs1

  • Results of a Pilot Adherence Activity for Pharmacy Learners on a Solid Organ Transplant Service

    J. Zumbrunnen

  • Results of Heart Transplantation from Donation After Circulatory Death (DCD) Donors Using Thoraco-Abdominal Normothermic Regional Perfusion (TA-NRP) Compared to Donation from Donation After Brain Death (DBD) Are Similar at One Year

    C. Gidea1, L. James2, D. E. Smith2, J. Carillo2, A. Reyentovich3, T. Saraon2, S. Katz2, S. Rao2, R. Goldberg2, B. Kadosh2, M. DiVita2, J. Cruz2, N. Sikand2, J. Ngai2, G. Piper2, N. Moazami2

  • Results Of The Ctot19 Trial: Infliximab (IFX) Induction Does Not Impact 2-year Outcomes In Deceased Donor Kidney Transplant Recipients

    P. Heeger1, B. Armstrong2, T. Alhamad3, D. Brennan4, J. Bromberg5, S. Bunnapradist6, S. Chandran7, R. Fairchild8, D. Foley9, R. Formica10, I. W. Gibson11, D. Hricik12, K. Kesler2, R. B. Mannon13, M. Menon10, K. Newell14, P. Nickerson11, J. Odim15, E. Poggio8, R. Sung16, R. Shapiro1, K. Tinckam17, F. Vincenti7

  • Retransplantation in a High-Volume Institution: Historical, Socioeconomic and Survival Trends

    D. von Ahrens, O. Sulimani, M. Holzner, M. Akhtar, S. Florman, A. Arvelakis

  • Revision Ureteroneocystostomy in Pediatric Renal Transplant Patients for Symptomatic Vesicoureteral Reflux and Its Effect on Recurrent Hospitalizations

    P. Campbell1, M. Christman1, S. Marietti2, E. Ingulli2

  • Revisiting Late Graft Loss or Death in Pediatric Liver Transplantation Through Analysis of the SPLIT Database

    J. E. Squires1, J. Bilhartz2, K. Soltys1, E. Hafberg3, G. V. Mazariegos1, N. Gupta4, R. Anand5, S. G. Anderson5, T. Miloh6

  • Revolutionizing Clinical Diagnostic Models for Acute Rejection Using Generative Adversarial Networks

    W. Yazar1, R. Nijor1, R. Sarwal1, N. Titzler1, M. Sarwal2, S. Ghosh1

  • Rhesus-Primatized Mouse Model Generated Using Transgenic Immunodeficient Mice

    C. Little1, W. J. Haynes1, L. Huang1, C. Daffada1, K. B. Wolfe2, E. Perrin2, J. A. Simpson1, J. A. Kropp Schmidt2, H. M. Hinkle2, L. T. Keding2, R. T. Behrens2, D. T. Evans2, D. Kaufman1, J. A. Thomson2, T. G. Golos2, M. Brown1

  • Rhinovirus Infection in Solid Organ Transplant Recipients

    G. Motoa1, M. A. Mendoza1, M. Raja1, J. Simkins2, S. Anjan2, E. Martin2, A. Phancao2, N. Sinha2, L. Abbo1, G. Guerra2, Y. Natori2

  • Risk Factors Associated with ICU Admission and Death in Patients Hospitalized with COVID-19 Differ Between Solid Organ Transplant and Non-Solid Organ Transplant Patients

    J. Schaenman, H. Byford, T. R. Grogan, Y. Motwani, O. Beaird, M. Kamath, E. Lum, K. Meneses, D. Sayah, D. Vucicevic, S. Saab

  • Risk Factors Associated with Medium-Term Allograft and Recipient Survival: Learned from 1,587 Adults with Single Kidney Transplantation

    S. Chang1, B. Liu1, D. Du1, N. Gong2, L. Zhu1, G. Chen1, W. Zhang1, Z. Chen2

  • Risk Factors for Early Post Transplant Cardiac Dysfunction After Liver Transplantation

    V. Subramanian1, K. Bowers2, H. Kalagotla2, J. Buggs1, N. Kemmer1, K. Dhanireddy1

  • Risk Factors for Extubation Failure Post- Lung Transplantation

    A. J. Trindade1, W. D. Gannon1, A. G. Dragnich1, G. Dahlberg1, C. T. Demarest2, E. S. Lambright2, K. A. McPherson1, S. G. Norfolk1, C. M. Shaver1, I. M. Robbins1, M. Bacchetta2

  • Risk Factors for Micafungin Non-Susceptible Invasive Candidiasis in Solid Organ Transplant Recipients

    U. Dhal, J. Morillas-Rodriguez, K. D. Brizendine

  • Risk for Loss of Hepatitis B Surface Antibody or Hepatitis B Reactivation in Kidney Transplant Recipients Receiving Lymphocyte Depleting Induction

    K. Paplaczyk1, C. Kane1, M. Kapugi1, K. Lang1, K. Cunningham1, C. D'Agostino1, J. Boike2

  • Risk of Clostridioides Difficile Infection After Kidney Transplant

    C. Thomas1, B. Crowther2, K. Schwarz2, D. Chen1, Y. Shandaliy1, K. Johnson1, P. Klem2

  • Risk of Post-Transplant Lymphoproliferative Disease After Anti-Thymocyte Globulin in Childhood Solid-Organ Transplant Recipients

    A. M. McKay1, C. Teoh1, J. Vasilevska-Ristovka2, J. Browne2, T. Banh2, A. Dipchand1, V. Ng1, M. Solomon1, U. Allen1, Y. Avitzur1, R. Parekh3

  • Risk of Tumor Recurrence, Functional Decline, and Metastatic Disease of Renal Transplant in Recipients with Hereditary Kidney Cancer: A Case Series

    M. Antony, A. Chaurasia, N. Gopal, Z. Kozel, M. Linehan, M. Ball

  • RNA Sequencing Profiling of Pretransplant Blood Identified Variant Allele Specific Expression of Leukocyte Immunoglobulin-Like Receptors (LILRs) Genes Associated with Graft Loss in Kidney Transplant Recipients

    Z. Sun1, Z. Yi1, Z. Zhang1, P. Cravedi1, M. Menon2, B. Murphy1, S. Chen3, W. Zhang1

  • RNA-Sequencing Analysis of Kidney Allografts Reveal Heightened NK Cell Activity in Chronic Active Antibody-Mediated Rejection

    Y. Shah, E. Varma, S. Rahim, C. Li, C. Snopkowski, C. Hughes, D. M. Dadhania, S. Salvatore, S. V. Seshan, O. Elemento, M. Suthanthiran, T. Muthukumar

  • Robotic Living Donor Nephrectomy: The Future is Now

    J. Yu, N. Vaccharajani, S. Matson, M. Scherer, J. Wellen, S. Shenoy, W. Chapman, M. Doyle, A. Khan

  • Robotic Partial Nephrectomy in Transplanted Kidney

    A. Kaviani, M. Abou Zeinab, M. Noble, Y. Lin, A. Wee, J. Kaouk, M. Eltemamy

  • Robotic-Assisted Reconstruction of the Transplant Ureter: A Minimally Invasive Option for a Rare Complication

    A. Popovic1, M. Hanlon2, S. Iskhagi2, R. Saidi2, S. Blakely3, R. Shahbazov2

  • ROImax Score: A Novel Predictor for Adherent Perinephric Fat in Healthy Donor for Transplantation Underwent Laparoscopic Donor Nephrectomy

    T. Noda, Y. Miyauchi, K. Nishimura, T. Fukumoto, N. Miura, T. Kikugawa, T. Saika

  • Role for Club Cell Secretory Protein in Inducing Exosomes and Activation of Immune Responses in Lung Transplanted Recipients for Cystic Fibrosis

    R. Ravichandran1, V. Kaza2, R. Bremner1, M. Smith1, T. Mohanakumar1

  • Role of CD8+T Cells Exhaustion in Long Term Spontaneous Acceptance of Mouse Kidney Allograft

    J. Ge1, E. Szuter1, T. Yokose1, I. Rosales2, A. Cuenca3, P. Russell1, J. Madsen1, R. Colvin2, A. Alessandrini1

  • Role of Circulating Tumour Cells in the Management of the Liver Transplant Patient with Hepatocellular Carcinoma

    F. Villalba1, F. Alconchel2, L. Sáenz3, M. Sánchez-Lorencio1, D. Ferreras2, P. Cascales2, F. Sánchez-Bueno2, R. Robles2, P. Ramírez2

  • Role of Group 2 Innate Lymphoid Cells in Murine Heart Transplant

    J. Ge1, L. Ott1, A. Das1, J. Markmann2, A. Cuenca1

  • Role of Innate Immunity in Regulating Host Responses to Ischemia and Reperfusion and Allograft Rejection Injury in Vascularized Composite Allotransplantation

    S. Han1, X. Lai2, J. Wang1, L. VanOsdol3, C. Chen1, J. Mathew1, J. R. Leventhal4, Z. Zhang5

  • Role of Mitochondrial Transplantation in Enhancing Liver Regeneration Following Partial Hepatectomy

    G. Lamanilao1, C. Watkins1, C. Kuscu1, C. Kuscu1, J. Eason2, A. Bajwa1

  • Role of Urinary Biomarkers in RWE Clinical Paradigm

    W. Yazar1, R. Sarwal2, N. Titzler1, M. Sarwal1, S. Ghosh2

  • Role of Vaccination in the COVID-19 Nationwide Cohort (N3C) of Solid Organ Transplant Recipients

    A. J. Vinson1, A. Anzalone2, R. Dai2, E. French3, A. Olex3, J. Sun4, G. Agarwal5, S. Lee6, R. B. Mannon7

Jump to:  View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences